Syntec Optics (Nasdaq: OPTX) Chairman & CEO to Keynote the Future of Photonics that Enables the Tech Frontier from Artificial Intelligence to Quantum and Defense
September 24, 2024 08:14 ET
|
Syntec Optics
ROCHESTER, NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- With nearly 11% of the global GDP light-enabled, Syntec Optics Chairman and CEO Al Kapoor is excited to deliver a keynote speech at the Global...
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX”
September 24, 2024 08:01 ET
|
Scienture Holdings, Inc.
TRxADE Health, Inc. today announced that it changed its name and ticker symbol to “Scienture Holdings, Inc.” and “SCNX”, respectively, and that the business will continue as a Nasdaq-listed company. ...
Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results
September 24, 2024 08:01 ET
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Company to host conference call today at 8.30 a.m. ETContinued progress within core activities in RNA delivery, supported by move into new...
America’s Car-Mart, Inc. Announces Appointment of Chief Operating Officer
September 24, 2024 08:00 ET
|
America's Car-Mart, Inc.
ROGERS, Ark., Sept. 24, 2024 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) (Car-Mart), one of the largest publicly held automotive retailers in the United States focused exclusively on...
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
September 24, 2024 08:00 ET
|
Aligos Therapeutics
SOUTH SAN FRANCISCO, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through...
Immutep Receives A$3.6 million R&D Tax Incentive from French Government
September 24, 2024 08:00 ET
|
Immutep Limited
Media Release SYDNEY, AUSTRALIA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company”), a biotechnology company developing novel LAG-3 related...
Certara’s Simcyp Consortium Celebrates 25th Anniversary
September 24, 2024 08:00 ET
|
Certara
Certara, a global leader in model-informed drug development, today announced the celebration of the 25th anniversary of the Simcyp® Consortium.
Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K Platform
September 24, 2024 08:00 ET
|
Standard BioTools Inc.
Standard BioTools achieves new record of the most protein measurements on the most sample types with expansion of the SomaScan® 11K Platform
Matthews International Announces Pricing of Senior Notes
September 24, 2024 08:00 ET
|
Matthews International Corporation
PITTSBURGH, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Matthews International Corporation (NASDAQ GSM: MATW) (the “Company”) has priced its previously announced private offering of $300 million aggregate...
Spectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites
September 24, 2024 08:00 ET
|
Spectral AI, Inc.
DALLAS, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...